Facilitators and Barriers to Cancer Treatment Among Texas Residents
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Interviews, Focus Groups.
- Who it may be relevant to
- Registry conditions: Cancer. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This trial uses semi-structured interviews and focus groups to determine facilitators and barriers of receiving timely cancer treatment among multiple cancers, across multiple insurance types, throughout Texas
Detailed description
Primary Objectives:
Aim 1: To comprehensively assess barriers to and facilitators of receiving timely cancer treatment, via in-depth telephone interviews among a purposive sample of Texas patients with Stage I-IV breast, colorectal, lung, and prostate cancer and diverse backgrounds.
Aim 2: To generate consensus on barriers and facilitators, as well as their relative importance, via focus groups, among carefully selected Texas patients with Stage I-IV breast, colorectal, lung and prostate cancer and diverse backgrounds,
Interventions
- Other Interviews
A 30 to 45-minute in-depth semi-structured interview by phone will be administer, following a semi-structured interview guide. - Other Focus Groups
45 to 60 minutes video conference
Primary outcome measures
- 1. Safety and Adverse Events (AEs) [Time frame: Through study completion; an average of 1 year]
Eligibility criteria
Inclusion criteria
Aims 1 and 2
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Verbal consent will be obtained
- Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study
- Males and females; Age ≥ 18 years old
- Documented diagnosis of breast, colorectal, lung, and prostate cancer patients, stage I-IV
- Either English or Spanish-speaking
Exclusion criteria
Aims 1 and 2
An individual who meets any of the following criteria will be excluded from participation in this study:
- Patients who are cognitively impaired
- Pregnant women
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Non-randomized
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Health services research
Study locations
United States · 1 center
- The University of Texas M. D. Anderson Cancer Center — Houston
Identifiers
NCT: NCT07105046 · 2025-0697 · NCI-2025-05584